SONG,Hongli

Hongli Song
Chief physician

Work Address:  24 fukang road, nankai district, Tianjin City.

Telephone:  022-23626928

Fax:  022-23626928

E-mail:  hlsong26@163.com

Biography

1. Research Interest:

(1) Basic and clinical research of stem cells in transplantation immunity and organ repair;

(2) Basic and clinical research on preventing recurrence of primary disease after liver transplantation;

(3) Effects of intestinal flora on end-stage liver disease.

2. Educational Background

Time

University

Professional

Degree

1982,9-1987,7

Jinzhou medical college

Clinical Medicine

Bachelor's degree

1998,9-2001,7

Dalian medical university (Department of   internal medicine digestive disease)

Clinical Medicine

Master's degree

2002,9-2005,7

China medical university (Department of   infectious diseases of internal medicine)

Clinical Medicine

Doctor's degree

3.Work Experience

Time

Work   unit

Administrative   position

technical   position

1987,9-1993,7

Dalian No. 6   people's hospital

No

Physician

1993,8-1994,7

Dalian foreign   language university

(overseas personnel training - official   study)

No

Further study

1994,8-1995,7

Dalian No. 6 people's   hospital

No

Attending   Physician

1995,9-1996,7

The first   affiliated hospital of Beijing medical university

No

Further study

1996.9-2002.7

Dalian No. 6   people's hospital

Head of   department

Deputy   director/Chief physician

2005.7-现在

Tianjin First Center   Hospital

Director /No

Chief   physician

4. Awards

In 2016, I was awarded the first batch of experts with outstanding contributions in Tianjin

5. Social Service

(1) Member of the standing committee of the liver failure and artificial liver division of the infectious diseases branch of the Chinese medical association

(2) Member of the end-stage liver disease division of the hepatology branch of the Chinese medical association

(3) Member of the organization and cell transplant professional committee of the organ transplant doctor branch of the Chinese medical doctor association

(4) Member of infection department of Chinese medical doctor association

(5) The fourth Tianjin medical association liver disease branch committee vice - chairman member

(6) Vice chairman of the 5th Tianjin integrated Chinese and western medicine liver disease branch

(7) Standing committee of infectious diseases branch of Tianjin medical association

(8) Member of fatty liver and autoimmune liver disease group, gastroenterology branch, Tianjin medical association

Achievements

First author/corresponding author publishes paper:published 32 papers in total(Among them, SCI has included 12 English papers)

 

No

Thesis   Name

Published   journal

Published   time

1

Heme   oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute   rejection and improving small bowel transplantation outcomes in rats

Stem Cell Res Ther.

2016   Nov 20;7(1):164. (SCI, IF: 4.504)

2

Improvement   of Liver Transplantation Outcome by Heme Oxygenase-1-Transduced Bone Marrow   Mesenchymal Stem Cells in Rats.

Stem Cells Int.

2016;2016:9235073(IF: 3.687)

3

Effects   of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation   and energy metabolism following liver transplantation.

World J Gastroenterol.

2017;23(19):3449-3467.   (SCI, IF: 3.365)

4

Immunomodulatory   effects of bone marrow mesenchymal stem cells overexpressing heme   oxygenase-1: Protective effects on acute rejection following reduced-size   liver transplantation in a rat model.

Cell Immunol.

2017   Mar; 313:10-24. (SCI, IF: 3.172)

5

Protective   effects of heme oxygenase-1-transduced bone marrow-derived mesenchymal stem   cells on reduced‑size liver transplantation: Role of autophagy regulated by   the ERK/mTOR signaling pathway.

Int J Mol Med.

2017;40(5):1537-1548.

(SCI, IF: 2.341)

6

Effect   of Heme oxygenase-1 transduced bone marrow mesenchymal stem cells on damaged   intestinal epithelial cells in vitro.

Cell Biol Int.

2017;41(7):726-738.(SCI, IF: 1.831)

7

Biological   effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro.

Mol Med Rep.

2017;15(5):2551-2559.   . (SCI, IF: 1.724)

8

Mesenchymal   stem cells improve the outcomes of liver recipients via regulating CD4+ T   helper cytokines in rat.

HPDI

2016,   15(3):257-265. . (SCI, IF: 2.341)

9

Effects   of dendritic cells from hepatitis B virus transgenic mice-stimulated autologous   lymphocytes on hepatitis B virus replication: A study on the impact of   specific sensitized effector cells on in vitro virus replication.

Viral Immunol,

2015,28(2):85-92.

(SCI, IF: 1.446)

10

Inhibition of HBV Replication in   HepG2.2.15 Cells by Human Peripheral Blood Mononuclear Cell-Derived Dendritic   Cells.

Annals of Clinical & Laboratory Science.

2015, 45(5):403-409. (SCI, IF: 0.91)

11

Reduction of Acute Rejection by Bone   Marrow Mesenchymal Stem Cells during Rat Small Bowel Transplantation.

PloS One.

2014,15;9(12):e114528. (SCI, IF: 3.234)

12

Protective effect of bone marrow   mesenchymal stem cells in intestinal barrier permeability after heterotopic   intestinal transplantation.

World Journal of Gastroenterology (WJG),

2014, 20(23): 7442- 7451. (SCI, IF:2.369)

13

Bone marrow   mesenchymal stem cells (MSCS) were used to repair the dead heart and donate   donor liver

Chinese journal of hepatobiliary   surgery

2017,23(4):   259-264.

14

Heme oxygenase-1   enhanced bone marrow mesenchymal stem cells to alleviate intestinal graft   rejection.

Chinese journal of experimental   surgery

2018,35(8):1469-1472.

Projects

Name   of Awards/

Achievements/Project   

Name   project funding

Category   project/ certificate no

Project   annual

The protective effect of HO-1 gene -   modified bone marrow MSCs on small - volume liver transplantation and its   molecular mechanism(No.81270528)

National   natural science foundation projects

Registration number of scientific and   technological achievements: Jin- 20171090

2017

Protective effect of bone marrow   mesenchymal stem cells modified with CXCR3/ HO-1 gene on small intestinal   transplantation and its mechanism(No.81441022)

National   natural fund emergency management program

Registration number of scientific and   technological achievements: Jin- 20161517

2016

Experimental study on the protective   effect of HO-1 modified MSCs on small-volume liver transplantation(No.12JCZDJC25200)

Tianjin   applied foundation and frontier technology research project(Key   point)

Registration number of scientific and   technological achievements: Jin- 20152230

2015

Study on the effect of ho-1 gene modified BMMSCs on   repairing DCD donor liver and its molecular mechanism in room temperature   mechanical perfusion system (No.81670574)

National natural science foundation projects

Under study

2017

Tianjin organ transplant clinical medical research center   (subproject)

Tianjin science and technology project

Under study

2016